BiotechTube
Genabio Diagnostics

Genabio Diagnostics

San Diego, United States· Est.
genabio.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $500K

Overview

Genabio Diagnostics is a private, pre-revenue diagnostics company established in 2015 in San Diego, California. The company operates in the infectious disease diagnostics sector, aiming to leverage its team's scientific and clinical lab expertise to develop novel detection products. While specific technology details and pipeline programs are not publicly disclosed on its currently non-functional website, the company's stated focus aligns with a high-growth global market. As a young, privately-held entity, its financial position and operational scale remain unclear without further public information.

Infectious Diseases

Technology Platform

Undisclosed platform for infectious disease detection, likely involving molecular or immunoassay techniques.

Funding History

1
Total raised:$500K
Grant$500K

Opportunities

The global infectious disease diagnostics market is large and growing, fueled by pandemic preparedness and demand for rapid, point-of-care tests.
Opportunities exist in developing multiplexed panels, faster/cheaper assays, and tests for underserved pathogens or antimicrobial resistance.

Risk Factors

High uncertainty regarding company's operational status and funding.
The diagnostics market is intensely competitive, requiring significant capital for development, clinical validation, and regulatory approval.
Lack of public information on technology or leadership presents substantial execution and credibility risks.

Competitive Landscape

The infectious disease diagnostics sector is dominated by large players like Abbott, Roche, Danaher, and bioMérieux, alongside numerous agile startups. Competition is based on test accuracy, speed, cost, ease of use, and menu breadth, creating a high barrier to entry for new companies.

More companies in United States →